Filter by: Open opportunities | Closed opportunities
![](https://i0.wp.com/www.healthinnowest.net/wp-content/uploads/2024/07/Eureka-disaster-thumbnail.png?fit=372%2C253&ssl=1)
Innovate UK: Eureka disaster resilience programme collaborative research and development 2024
open-opportunity“UK registered organisations can apply for a share of up to £1 million to develop technologies in the field of Disaster Resilience, Response and Recovery, in partnership with organisations from participating Eureka countries.”
Cheryl Scott
Industry and Innovation Lead
The aim of this competition is to support international collaboration on R&D projects that create innovative products, processes or services for commercialisation. It will fund projects in the field of Disaster Resilience, Response and Recovery. Your project must have high market potential and develop at least one of the following: innovative products, technology-based applications, technology-based services.
![](https://i0.wp.com/www.healthinnowest.net/wp-content/uploads/2024/07/KTP-thumbnail.png?fit=372%2C253&ssl=1)
Innovate UK: Knowledge transfer partnerships (KTP): 2024 to 2025 Round 3
open-opportunity“UK registered academic institutions can apply for a share of up to £9 million to fund innovation projects with businesses or not for profits.”
Alex Leach
Deputy Director of Programmes
The Knowledge Transfer Partnership (KTP) programme allows a UK registered business or not for profit organisation, (which we will refer to collectively as the ‘business partner’ from now on) to partner with a ‘knowledge base partner’, which is either a UK higher education (HE) or further education (FE) institution, research and technology organisation (RTO) or Catapult.
![](https://i0.wp.com/www.healthinnowest.net/wp-content/uploads/2024/04/EIC-Accelerator-thumbnail.png?fit=372%2C253&ssl=1)
Innovate UK: Accelerated Knowledge Transfer 3 2024
open-opportunity“UK registered academic institutions can apply for a share of up to £1 million to fund innovation projects with businesses and not for profit organisations.”
Ben Hugill
Innovation Advisor
The Innovate UK Accelerated Knowledge Transfer (AKT) scheme will support a Knowledge Base partner, in working with their Business Partner, to deliver a short, rapid and targeted intervention. This intervention will accelerate the evaluation or development of an innovation project or concept, with the potential for a significant impact for the Business Partner.
![](https://i0.wp.com/www.healthinnowest.net/wp-content/uploads/2024/07/Stroke-Programme-thumbnail.png?fit=372%2C253&ssl=1)
SBRI Healthcare competition 26 - Stroke
open-opportunity“Call looking for innovations that make specialist care and treatments available to more patients in a more timely and efficient manner, and further enhance the delivery of rehabilitation to improve their recovery after a stroke.”
Ben Hugill
Innovation Advisor
Under this Phase 3 Funding Competition, three challenges have been identified via consultation with clinicians and other stakeholders working in provision of care across the spectrum and review of the James Lind Alliance Stroke Priority Setting Partnership for Stroke Research: early diagnosis, rehabilitation, life after stroke.
![](https://i0.wp.com/www.healthinnowest.net/wp-content/uploads/2024/01/health-care-professionals-thumb.jpg?fit=372%2C253&ssl=1)
SBRI Healthcare competition 26 - Urgent and Emergency Care
open-opportunity“Pressure on urgent and emergency care services is growing, this call seeks to find innovations that can help.”
Ben Hugill
Innovation Advisor
Competition 26 – Urgent & Emergency Care, Phase 3, aims to identify innovations at an advanced stage of development that address three priority areas: health and care outside of hospitals: accessing the right care and reducing demand, reducing length of stay and improving discharge, supporting workforce.
![](https://i0.wp.com/www.healthinnowest.net/wp-content/uploads/2023/05/medtech-research-thumbnail.jpg?fit=372%2C253&ssl=1)
SBRI healthcare competition 25 - AMR
open-opportunity“The NHS Long Term Plan identifies antimicrobial resistance as one of five priorities requiring NHS action on prevention, and reiterates the UK’s 20-year vision for AMR which outlines the aim for a world in which antimicrobial resistance is effectively contained, controlled and mitigated. AMR is a significant threat to public health and this programme is looking for innovations that can help.”
Cheryl Scott
Industry and Innovation Lead
Under the overall theme of “Antimicrobial resistance (AMR)”, Competition 25 Phase 1 invites early-stage innovations in the following four priority areas: point of care diagnostics, monitoring, and susceptibility testing, prescribing decision support and risk stratification, novel care delivery methods, infection prevention and control (IPC).